Mixed Bacterial-Fungal Otitis Externa

Mixed bacterial-fungal otitis externa is an infectious and inflammatory condition affecting the skin of the external auditory canal, in which bacterial pathogens and pathogenic or opportunistic fungi are present simultaneously. The most characteristic symptoms include itching, pain, a feeling of pressure or blockage in the ear, tenderness when pressing on the tragus, swelling of the ear canal, redness, oozing, an unpleasant odor, whitish, gray, yellow, brown, or black discharge, crusting, and temporary hearing loss. The bacterial component is most commonly associated with Pseudomonas aeruginosa, Staphylococcus aureus, and other skin bacteria, while the fungal component is associated with Aspergillus, Candida, and, less commonly, other micromycetes. Infection may develop after water enters the ear, trauma caused by cotton swabs, scratching, use of in-ear headphones or hearing aids, use of topical antibiotics, or disruption of the skin's acidity and protective lipid layer. A mixed infection is especially likely after incomplete or incorrectly selected treatment of bacterial otitis, when an antibiotic suppresses part of the bacterial flora but creates conditions favorable for fungal colonization. The primary target tissues are the epidermis of the ear canal, hair follicles, sebaceous glands, and ceruminous glands; in severe cases, inflammation may spread to the auricle, tympanic membrane, soft tissues, and bony structures at the base of the skull. In children, swelling can obstruct the narrow ear canal more quickly; in older patients, particularly those with diabetes mellitus, the risk of invasive disease is increased; in adults, the condition is more often associated with water exposure, ear trauma, and topical self-treatment. An uncomplicated exacerbation usually lasts from several days to two weeks, but with mixed infection, failure to clean the ear canal, or an incorrect choice of ear drops, the condition may persist for several weeks, recur, or become chronic.

How to Tell Whether You Have Mixed Bacterial-Fungal Otitis Externa

A mixed infection may be suspected when marked pain, swelling, and oozing purulent discharge occur together with intense itching, a foreign-body sensation, loose fungal debris, flaky deposits, or dark pinpoint inclusions. Pain, marked tragal tenderness, pronounced swelling, and purulent discharge are more typical of the bacterial component, while persistent itching, a blocked-ear sensation, scaling, films, and an unusual color of the material in the ear canal are more typical of the fungal component. However, the full composition of the microflora cannot be reliably determined by appearance alone. At home, it is acceptable only to assess whether there is discharge at the entrance to the ear canal, its odor, tragal tenderness, hearing reduction, and whether worsening is associated with water entering the ear or with the use of ear drops. The ear must not be examined deeply with a cotton swab, camera, hairpin, or any other object. The diagnosis is confirmed by an otorhinolaryngologist using otoscopy or otomicroscopy, assessment of the tympanic membrane, removal of debris, and microscopic examination of the discharge. In recurrent, severe, or persistent disease, bacterial culture with antibiotic susceptibility testing and mycological examination are required. If the pain is felt deeper in the ear, tragal tenderness is absent, fever is present, or discharge appeared after rupture of the tympanic membrane, otitis media must be excluded. If scaling predominates without purulent discharge, evaluation for contact, atopic, or seborrheic dermatitis is indicated.

Red Flags

Immediate evaluation by an otorhinolaryngologist is required if pain rapidly intensifies or becomes throbbing at night and appears disproportionate to the visible condition of the ear canal, because necrotizing otitis externa involving cartilage, bone, and the skull base may begin in this way. This course is particularly dangerous in patients with diabetes mellitus, cancer, immunodeficiency, after transplantation or chemotherapy, or during long-term use of immunosuppressants. Urgent medical care is required in the presence of fever, chills, spread of redness and swelling to the auricle, face, or neck, swelling behind the ear, pronounced weakness, or signs of intoxication. Dizziness, impaired balance, sudden hearing loss, tinnitus, double vision, difficulty swallowing, hoarseness, facial asymmetry, or weakness of the facial muscles may indicate involvement of the inner ear or cranial nerves and require urgent examination. Bloody discharge, ear trauma, a suspected foreign body, chemical burn, or possible tympanic membrane perforation rule out self-administration of any solutions into the ear. A young child, pregnant woman, older patient, or person with severe chronic illnesses should be examined by a doctor earlier, especially if there is pain, fever, refusal to eat, sleep disturbance, or rapid deterioration. Fungal and mixed necrotizing otitis externa are rare but occur predominantly in immunocompromised patients and may be accompanied by mixed microbial flora.

Initial Self-Care Measures for Mixed Bacterial-Fungal Otitis Externa

Until medical examination, water must be kept completely out of the affected ear, and swimming, baths, saunas, in-ear headphones, earplugs, and use of a hearing aid on the affected side should be avoided if temporarily removing the hearing aid is safe. During a shower, the outer opening of the ear canal may be protected with a dry cotton ball lightly coated with petroleum jelly on the outside, without pushing it into the canal; the protection should be removed immediately after the shower. It is preferable to sleep on the healthy side without pressing the inflamed ear against the pillow. Physical activity is acceptable when body temperature is normal and severe pain is absent, but activities associated with heavy sweating or contact with water should temporarily be avoided. No special diet is required. In the presence of fever or intoxication, room-temperature water may be consumed in small portions within the person's usual individual fluid requirements; increased fluid intake should be limited in heart or kidney failure. In diabetes, blood glucose should be monitored more frequently because hyperglycemia impairs local immune defense and increases the risk of invasive disease.

Only discharge that has drained spontaneously onto the auricle may be gently blotted with a sterile dry tissue. The ear canal must not be irrigated with water, hydrogen peroxide, alcohol, vinegar, boric acid, baking soda, chlorhexidine, herbal infusions, or oils until the integrity of the tympanic membrane has been confirmed. The ear must not be heated, and hot compresses, ear candles, hair dryers, cotton swabs, tweezers, matches, or homemade ear wicks must not be used. Leftover antibiotic, antifungal, and hormonal ear drops must not be combined without medical supervision: an unsuitable antibiotic may promote fungal growth, while a corticosteroid may suppress the local immune response and mask progression of the infection. Pain intensity, the amount and odor of discharge, body temperature, spread of swelling, hearing, and the appearance of dizziness should be monitored daily. In the presence of severe pain, purulent discharge, diabetes, or immunodeficiency, examination is required on the same day; with moderate symptoms, absence of improvement within twenty-four to forty-eight hours is also an indication for consultation with an otorhinolaryngologist.

Stages and Possible Progression of Mixed Bacterial-Fungal Otitis Externa

Specific latent and prodromal stages are not defined for otitis externa. Usually, the skin barrier is first disrupted by moisture, microtrauma, dermatitis, frequent removal of earwax, or exposure to medicated ear drops. Itching, discomfort, and a sensation of moisture then develop, followed by increasing pain, swelling, discharge, and blockage of the ear canal. The fungal component may be present from the onset of the disease or may develop secondarily after antibacterial therapy. With a favorable course, professional cleaning and pathogen-directed topical treatment lead to regression of inflammation, restoration of the epidermis, and normalization of hearing. Persistence of fungal debris, a humid climate, swimming, microtrauma, hearing aids, eczema, psoriasis, an anatomically narrow ear canal, diabetes mellitus, immunodeficiency, and repeated use of antibiotics without identification of the pathogen contribute to recurrence. Chronic disease is accompanied by persistent itching, thickening and scaling of the skin, stenosis of the ear canal, and recurrent infectious exacerbations. Without treatment, furunculosis, perichondritis of the auricle, inflammation of the tympanic membrane, persistent narrowing of the ear canal, conductive hearing loss, and spread of infection to surrounding tissues may occur. The most dangerous complication is necrotizing otitis externa with osteomyelitis of the temporal bone and involvement of the cranial nerves. Recurrences of otomycosis are not uncommon, especially after ear surgery and in patients with immune disorders.

Integrative Treatment Methods for Mixed Bacterial-Fungal Otitis Externa

Integrative therapy begins with otoscopy, confirmation of the integrity of the tympanic membrane, and professional removal of bacterial and fungal debris. No topical medication can work effectively if the ear canal is filled with pus, mycelium, crusts, and desquamated epithelium. In mixed infection, it is also important to determine which bacteria and fungi are involved in the inflammatory process, because suppressing only one component may allow the other to persist or become more pronounced.

The main topical preparation is ABP-153 oil infusion. The basic version without DMSO is intended for superficial and cavity-localized processes in the external auditory canal. Its clinical purposes are to provide local anti-inflammatory, antimicrobial, antifungal, antipruritic, and reparative support for damaged epithelium. ABP-153 is used only after the ear canal has been cleaned and the integrity of the tympanic membrane has been confirmed. In cases of perforation, the presence of a ventilation tube, previous middle-ear surgery, bloody discharge, pronounced dizziness, or an unknown condition of the tympanic membrane, the preparation should not be introduced without a decision by an otorhinolaryngologist. Burning, irritation, increased itching, and an allergic reaction are possible. The penetration-enhanced version ABP-153D containing 7% DMSO offers no clinical advantage in superficial otitis externa and imposes greater safety requirements, so it is not included in the regimen discussed here.

Jindu ear drops contain chlorhexidine acetate, Erionota torus larval extract, Saussurea costus, Dendrobium nobile, Vitex trifolia, Cyathula officinalis, magnetite, and borneol. The preparation is intended to provide local antiseptic, antifungal, anti-inflammatory, antipruritic, and anti-edematous effects. It may be considered as an alternative to ABP-153 or as a separate stage of therapy, but the two products should not be instilled one after another without supervision. The oil base of ABP-153 may alter the distribution of an aqueous solution, while combining several multicomponent products makes it more difficult to identify the cause of irritation or allergy. Jindu drops are contraindicated in cases of tympanic membrane perforation or unknown membrane integrity, a foreign body, significant traumatic injury, or allergy to any of the ingredients. Burning, dryness, irritation, and contact dermatitis may occur.

For internal use in recurrent or prolonged disease, the preferred powdered extract is Coptis chinensis. Its alkaloid complex is considered a systemic antimicrobial, antifungal, and anti-inflammatory component, particularly when otitis externa is accompanied by other manifestations of dysbiosis, candidiasis, or metabolic disorders. Coptis does not replace local debridement or pathogen-directed otic medications. It is contraindicated in individual hypersensitivity, marked gastric hypoacidity, and chronic hepatitis with cholestasis. Possible adverse effects include nausea, a bitter taste in the mouth, reduced appetite, abdominal discomfort, and headache. The possibility of enhanced effects of glucose-lowering, antihypertensive, anticoagulant, and antiarrhythmic drugs should be taken into account, as should interactions with medications metabolized through CYP3A4 and P-glycoprotein.

Nigella sativa in powdered-extract form is used orally as an additional anti-inflammatory, immunomodulatory, and antimicrobial component. It may be particularly appropriate when infection is accompanied by eczematous, atopic, or allergic inflammation of the skin of the ear canal and a tendency to recur. Additional oil-based otic forms of Nigella are not used simultaneously with ABP-153 because this would duplicate topical therapy. Allergic reactions, dyspepsia, loose stools, and reductions in blood pressure or blood glucose may occur. Caution is required in hypotension, hypoglycemia, and during use of anticoagulants, antiplatelet drugs, antihypertensive medications, and glucose-lowering agents.

Curcuma longa in powdered-extract form is used orally as an anti-inflammatory and antioxidant component that supports restoration of damaged tissues. It does not replace antimicrobial or antifungal treatment and has a lower priority than Coptis. Turmeric is contraindicated in biliary obstruction, exacerbation of gallstone disease, active ulcerative lesions of the gastrointestinal tract, and clinically significant bleeding. Heartburn, nausea, abdominal pain, and diarrhea may occur. Combination with anticoagulants or antiplatelet agents may increase the risk of bleeding.

Scutellaria baicalensis in powdered-extract form may be included when there is a pronounced inflammatory-allergic component, persistent itching, irritability, or sleep disturbance caused by pain. Its role remains supplementary. Drowsiness, dizziness, weakness, and decreased blood pressure are possible. Scutellaria may enhance the effects of hypnotic, sedative, anxiolytic, and anticonvulsant drugs. Caution is required in liver disease, hypotension, and work requiring a high level of concentration.

The Five Root Compound anti-inflammatory formula in powdered form is taken orally when inflammatory pain and swelling of the ear canal are pronounced. It does not mechanically remove accumulated fungal debris and does not replace antibacterial or antifungal therapy. Its clinical purpose is to reduce the intensity of inflammation, pain, and tissue edema without the typical risks associated with systemic NSAIDs, such as erosive and ulcerative gastric injury, gastrointestinal bleeding, fluid retention, and impaired renal perfusion. However, individual intolerance to plant ingredients, nausea, abdominal pain, or diarrhea may also occur. The formula contains Harrisonia perforata, Capparis micracantha, Clerodendrum petasites, Ficus racemosa, and Tiliacora triandra.

The Antipyretic Compound is not part of the basic treatment of uncomplicated otitis externa. It may be considered only in confirmed fever after a physician has excluded otitis media, perichondritis, cellulitis, a necrotizing process, and spread of the infection. Simply suppressing fever without establishing a diagnosis may mask deterioration.

An integrative regimen should not become the simultaneous use of every product listed above. The foundation is cleaning of the ear canal and one clinically justified topical preparation. Powdered extracts for internal use are selected according to the leading mechanisms, comorbid conditions, and potential drug interactions. In bacteriologically or mycologically confirmed infection, herbal formulas are used as part of comprehensive therapy and not as a reason to refuse a necessary antibiotic or antifungal medication. Their advantage lies in the possibility of providing multicomponent anti-inflammatory, antimicrobial, and reparative effects with a lower likelihood of systemic nephrotoxicity, ulcerative gastrointestinal damage, hematopoietic disorders, and tendon injury characteristic of certain chemically synthesized drugs. However, plant origin does not eliminate the possibility of allergy, hepatotoxicity, changes in blood pressure or glycemia, or drug interactions.

What You Need to Know About Standard Protocols in Modern Medicine

The basis of treatment is not the mechanical instillation of several medications one after another but thorough removal of pus, fungal mycelium, crusts, and desquamated epithelium under direct visualization. Microsuction and careful instrumental cleaning of the ear canal are used. If swelling is pronounced, the doctor may place a special wick or ear dressing to deliver medication. Irrigation is permissible only when the tympanic membrane is known to be intact; if it is perforated, fluid and potentially ototoxic substances may enter the middle ear. Mechanical cleaning sometimes has to be repeated because residual debris sustains infection and blocks the action of ear drops.

Topical ciprofloxacin and ofloxacin are prescribed against susceptible Gram-negative and Gram-positive bacterial flora. An important advantage is their relatively low risk of ototoxicity when the integrity of the tympanic membrane is unknown compared with aminoglycosides. Burning, itching, pain, irritation, dermatitis, an unpleasant taste if the medication passes through a perforation, and allergic reactions may occur. Prolonged or repeated use creates selective pressure, promotes bacterial resistance, and may support fungal superinfection. Fluoroquinolone ear drops should not be started independently in patients allergic to this class of drugs or without assessing the causes of recurrent disease.

Neomycin and other aminoglycosides are used against selected bacterial pathogens, often in combination with polymyxin and a corticosteroid. A critically important point is that drugs in this group must not be used without supervision when the tympanic membrane is perforated, after middle-ear surgery, or when a ventilation tube is present because of the risk of damage to the cochlea and vestibular apparatus. Neomycin frequently causes allergic contact dermatitis, which manifests as increased itching, redness, and oozing and may mistakenly be interpreted as progression of the infection. Repeated courses increase the risk of sensitization, bacterial resistance, and replacement of the bacterial flora by fungi.

Polymyxin B acts primarily against Gram-negative bacteria and is used in combination ear drops. Irritation, contact dermatitis, and allergy are possible. If the tympanic membrane is damaged, combination products containing potentially ototoxic ingredients require particular caution. The narrow spectrum of polymyxin prevents it from being used as a universal treatment for mixed infection.

Topical clotrimazole is active against many Candida and Aspergillus species and is usually used after fungal debris has been removed. Burning, increased itching, irritation, redness, contact dermatitis, and, rarely, a pronounced allergic reaction may occur. Systemic absorption with local administration is limited, so clinically significant effects on the liver, kidneys, blood, nervous system, and endocrine system are unlikely. However, the dosage form must be suitable for use in the ear canal. A solution should not be introduced without medical supervision if the integrity of the tympanic membrane is unknown, after ear surgery, or in the presence of severe pain or dizziness.

Miconazole, econazole, and other topical azole antifungals may be used when susceptibility of the fungal flora has been confirmed. The main risks are local burning, irritation, maceration, contact allergy, and insufficient effectiveness when dense debris remains in the ear canal. Systemic drug interactions during local otic use are usually minimal, but the use of creams and solutions not intended for the ear without medical supervision may impair drainage and damage the inflamed epithelium.

Nystatin is mainly active against Candida but is not a universal agent against Aspergillus. Its use without mycological clarification may leave the mold component of the infection untreated. Itching, burning, and local allergic reactions may occur. In the presence of tympanic membrane perforation, the appropriate formulation should be selected by an otorhinolaryngologist.

Acetic acid and other acidifying solutions restore an acidic environment in the ear canal that is unfavorable for bacteria and fungi and may be used in some uncomplicated superficial forms. On inflamed, eroded skin, they may cause severe burning and pain. They should not be instilled independently when tympanic membrane perforation is possible, a ventilation tube is present, after surgery, or in pronounced swelling. Acidification does not replace antibacterial and antifungal treatment in confirmed mixed infection.

Hydrocortisone, dexamethasone, and other topical corticosteroids reduce swelling, itching, and inflammatory pain, thereby improving patency of the ear canal. At the same time, they suppress local immune responses, may mask ongoing infection, slow epithelial healing, thin the skin, and, with prolonged use, promote fungal growth. They must not be used as monotherapy for an active infection. Particular caution is required in diabetes, immunodeficiency, pronounced erosions, and suspected invasive disease. Withdrawal syndrome usually does not develop after a short local course, although abrupt discontinuation after prolonged uncontrolled use may be accompanied by recurrence of inflammation.

Systemic antibiotics are not the standard treatment for uncomplicated otitis externa because topical therapy achieves a higher drug concentration directly at the site of infection. They are used when infection spreads beyond the ear canal, in cellulitis, perichondritis, necrotizing disease, immunodeficiency, or when effective local treatment is not possible. Systemic fluoroquinolones may cause nausea, diarrhea, antibiotic-associated colitis, headache, insomnia, anxiety, sensory disturbances, QT-interval prolongation, fluctuations in blood glucose, tendon injury, peripheral neuropathy, and drug interactions. The risk of complications is higher in older patients, in renal impairment, cardiac rhythm disorders, concurrent corticosteroid use, and use of drugs that affect the QT interval. Uncontrolled administration of a systemic antibiotic in mixed infection may reduce bacterial inflammation while increasing fungal colonization.

Systemic antifungal medications are considered in invasive, necrotizing, or persistent fungal disease and require identification of the pathogen. Itraconazole and voriconazole may damage the liver, interact with many medications through cytochrome P450 enzymes, and cause nausea, rash, edema, cardiac rhythm disturbances, and neurological reactions. Itraconazole is dangerous in heart failure because of its negative inotropic effect. Voriconazole may cause visual disturbances, phototoxicity, severe skin reactions, and, with long-term use, periosteal disease. Fluconazole is active primarily against susceptible yeasts and does not provide reliable coverage of all Aspergillus species; it may increase liver enzymes, prolong the QT interval, and enhance the effects of anticoagulants, certain glucose-lowering medications, anticonvulsants, and other drugs.

A reliable percentage of complete recovery and absence of recurrence over two years specifically for mixed bacterial-fungal otitis externa has not been established. The outcome depends on removal of microbial debris, identification of both components of the infection, the condition of the tympanic membrane, pathogen susceptibility, concomitant dermatitis, diabetes, immune status, and avoidance of repeated trauma and moisture. Combined use of antibiotics, antifungals, corticosteroids, antiseptics, and analgesics without microbiological control increases the risk of contact dermatitis, epithelial damage, ototoxicity, selection of resistant bacteria, fungal superinfection, and masking of dangerous spread of the process; alternative integrative methods based on herbal formulas also exist and, when appropriately selected, may provide local anti-inflammatory, antimicrobial, and reparative support without the aggressive systemic effects characteristic of a number of chemically synthesized medications.

Why Dosages and Duration of Treatment Are Not Specified in This Article

Mixed bacterial-fungal otitis externa varies among patients in the severity of inflammation, composition of the microflora, depth of skin damage, amount of discharge, condition of the tympanic membrane, and tendency to recur. The condition may coexist with diabetes mellitus, immunodeficiency, dermatitis, psoriasis, liver and kidney disease, circulatory disorders, allergies, and consequences of previously used antibiotics or corticosteroids.

Determining the dosage and duration of treatment requires assessment of whether the disease is acute or chronic, the degree of swelling and stenosis of the ear canal, and the presence of erosions, oozing, pus, fungal mycelium, and complications. Age, body weight, pregnancy, the condition of the liver, kidneys, cardiovascular, nervous, endocrine, and immune systems, otoscopic and microbiological findings, and all medications already being taken must also be considered.

A single universal regimen may be insufficient for a persistent mixed infection or excessive for a superficial localized process. An inappropriate duration of treatment may lead to persistence of fungal mycelium, selection of resistant bacteria, skin irritation, contact dermatitis, or damage to structures of the middle and inner ear. Therefore, this article describes therapeutic approaches but does not replace an individual clinical and pharmacological assessment. If necessary, you may ask a short question in the comments to this article, and for more complex cases you may schedule a consultation with a clinical pharmacologist specializing in integrative medicine using this link: https://asiabiopharm.com/konsultaciii